Complement receptor 1 gene variants are associated with erythrocyte sedimentation rate.

[1]  Rongling Li,et al.  Quality Control Procedures for Genome‐Wide Association Studies , 2011, Current protocols in human genetics.

[2]  Wendy A. Wolf,et al.  The eMERGE Network: A consortium of biorepositories linked to electronic medical records data for conducting genomic studies , 2011, BMC Medical Genomics.

[3]  S. Shevkoplyas,et al.  Ligation of complement receptor 1 increases erythrocyte membrane deformability. , 2010, Blood.

[4]  Christopher G. Chute,et al.  A Genome-Wide Association Study of Red Blood Cell Traits Using the Electronic Medical Record , 2010, PloS one.

[5]  Dave Richard,et al.  Complement receptor 1 is the host erythrocyte receptor for Plasmodium falciparum PfRh4 invasion ligand , 2010, Proceedings of the National Academy of Sciences.

[6]  D. Briles,et al.  Complement Receptor 1 Expression on Mouse Erythrocytes Mediates Clearance of Streptococcus pneumoniae by Immune Adherence , 2010, Infection and Immunity.

[7]  H. Kang,et al.  Variance component model to account for sample structure in genome-wide association studies , 2010, Nature Genetics.

[8]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[9]  Dong Liu,et al.  The structure, genetic polymorphisms, expression and biological functions of complement receptor type 1 (CR1/CD35) , 2009, Immunopharmacology and immunotoxicology.

[10]  L. Kiemeney,et al.  Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer , 2009, Nature Genetics.

[11]  Nick C Fox,et al.  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes , 2009, Nature Genetics.

[12]  A. Bhandoola,et al.  Complement-dependent T-cell lymphopenia caused by thymocyte deletion of the membrane complement regulator Crry. , 2009, Blood.

[13]  R. Khera,et al.  Complement Receptor 1: Disease associations and therapeutic implications , 2008, Molecular Immunology.

[14]  K. Tokunaga,et al.  A functional single-nucleotide polymorphism in the CR1 promoter region contributes to protection against cerebral malaria. , 2008, The Journal of infectious diseases.

[15]  I. Ghiran,et al.  Ligation of erythrocyte CR1 induces its clustering in complex with scaffolding protein FAP-1. , 2008, Blood.

[16]  S. Perkins,et al.  The partly folded back solution structure arrangement of the 30 SCR domains in human complement receptor type 1 (CR1) permits access to its C3b and C4b ligands. , 2008, Journal of molecular biology.

[17]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[18]  Joost Schymkowitz,et al.  Bioinformatics Applications Note Snpeffect V2.0: a New Step in Investigating the Molecular Phenotypic Effects of Human Non-synonymous Snps , 2022 .

[19]  T. Giese,et al.  The complement receptor 1, CR1 (CD35), mediates inhibitory signals in human T-lymphocytes. , 2006, Molecular immunology.

[20]  J. Harley,et al.  Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: a meta-analysis , 2005, Human Genetics.

[21]  D. Kwiatkowski.  How malaria has affected the human genome and what human genetics can teach us about malaria. , 2005, American journal of human genetics.

[22]  T. Fandeur,et al.  A complement receptor-1 polymorphism with high frequency in malaria endemic regions of Asia but not Africa , 2005, Genes and Immunity.

[23]  Vilmundur Gudnason,et al.  C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. , 2004, The New England journal of medicine.

[24]  D. Birmingham,et al.  A human CR1-like transcript containing sequence for a binding protein for iC4 is expressed in hematopoietic and fetal lymphoid tissue. , 2004, Molecular immunology.

[25]  M. Bockarie,et al.  A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Pardis C Sabeti,et al.  Detecting recent positive selection in the human genome from haplotype structure , 2002, Nature.

[27]  J. Atkinson,et al.  Structure–function relationships of complement receptor type 1 , 2001, Immunological reviews.

[28]  I. Gigli,et al.  Evolutionary relationships among proteins encoded by the regulator of complement activation gene cluster. , 2000, Molecular biology and evolution.

[29]  M. Brigden.  Clinical utility of the erythrocyte sedimentation rate. , 1999, American family physician.

[30]  I. Kushner,et al.  Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.

[31]  R. Karr,et al.  Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[32]  N. Dracopoli,et al.  Current protocols in human genetics , 1994 .

[33]  I. Campbell,et al.  Three-dimensional structure of a complement control protein module in solution. , 1991, Journal of molecular biology.

[34]  G. R. Carson,et al.  Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. , 1990, Science.

[35]  T L Fabry,et al.  Mechanism of erythrocyte aggregation and sedimentation. , 1987, Blood.

[36]  M. Liang,et al.  The erythrocyte sedimentation rate. Guidelines for rational use. , 1986, Annals of internal medicine.

[37]  B. Bain.  Some influences on the ESR and the fibrinogen level in healthy subjects. , 1983, Clinical and laboratory haematology.